Quantitative assessment of emphysema and bronchial wall thickness in patients with stable chronic obstructive pulmonary disease: comparison between the eosinophilic and non-eosinophilic phenotypes

Author:

Stival Rebecca Saray Marchesini1ORCID,Rabelo Lêda Maria1ORCID,Leão Giovanna Lemes1ORCID,Drevenowski Diogo1ORCID,Serafini Joel1ORCID,Vieira Vítor Lopes Galvão1ORCID,Escuissato Dante Luiz1ORCID

Affiliation:

1. Universidade Federal do Paraná (UFPR), Brazil

Abstract

Abstract Objective: To perform a quantitative assessment of bronchial wall thickening and the emphysema score in patients with stable chronic obstructive pulmonary disease (COPD), comparing the eosinophilic and non-eosinophilic COPD phenotypes. Materials and Methods: This was a retrospective observational study of patients with COPD followed between August 2018 and July 2019. The patients were divided into two groups by the eosinophil count in peripheral blood: eosinophilic (≥ 300 cells/µL); and non-eosinophilic (< 300 cells/µL). Quantitative, automated assessments of emphysema and bronchial wall thickness were performed by evaluating computed tomography scans of the chest. Results: We evaluated the records of 110 patients diagnosed with COPD: 28 (25.5%) in the eosinophilic group; and 82 (74.5%) in the non-eosinophilic group. The demographic, clinical, functional, and therapeutic variables were comparable between the two groups. There were no significant differences between the two groups in terms of the emphysema score or bronchial wall thickness (p > 0.05 for both). Conclusion: Patients with eosinophilic COPD do not appear to have lower emphysema scores or greater bronchial wall thickening than do those with non-eosinophilic phenotypes of the disease.

Publisher

FapUNIFESP (SciELO)

Subject

Radiology, Nuclear Medicine and imaging

Reference18 articles.

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: the GOLD science committee report 2019;Singh D;Eur Respir J,2019

2. COPDGene® 2019: redefining the diagnosis of chronic obstructive pulmonary disease;Lowe KE;Chronic Obstr Pulm Dis,2019

3. Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD;Wedzicha JA;N Engl J Med,2016

4. Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO;Camp J;Med Sci (Basel),2018

5. Blood eosinophils as a marker of response to inhaled corticosteroids in COPD;Barnes NC;Eur Respir J,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3